Current Nosology of Treatment Resistant Depression: A Controversy Resistant to Revision
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Treatment-Resistant Depression (TRD) represents a source of ongoing clinical and nosological controversy and confusion. While no univocal consensus on its definition and specific correlation with major mood disorders has been reached to date, a progressively greater number of evidences tend to suggest a revision of current clinical nosology. Since a better assessment of TRD should be considered mandatory in order to achieve the most appropriate clinical management, this narrative review aims to briefly present current most accepted definitions of the phenomenon, speculating on its putative bipolar diathesis for some of the cases originally assessed as unipolar depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002 · cited 1×
“Prevalence estimates for TRD are available from several sources, including large clinical trials [4], large metaanalyses [5], or naturalistic studies [6-8].”
BackgroundResidual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 2×
“Also, most TRD cases have multiple co-morbidities and this further increases the burden load, reducing the chance of a substantial inter-episodic depressive symptoms resolution, therefore increasing the risk for relapse [15].”
BackgroundTraining and quality assurance with the structured clinical interview for DSM-iV (SCID-I/P)
Ventura, J., Liberman, R. P., Green, M. F., Shaner, A., & Mintz, J. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00038-9 · Cited by 591 · cited 2×
“Sharma et al. (2005) tried to answer at some of these questions investigating 69 patients diagnosed with treatment resistant-MDD (“failure to respond to 2 or more adequate clinical trials”) at a local mood clinic; when patients were retested using the Structured Clinical Interview for Axis-I disorders (SCID-I) [44] 35…”
BackgroundResidual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470 · cited 1×
“Finally, it is also worth noting that while partial or non-response are common, residual symptoms among remitters are also highly prevalent [12, 13], being usually associated with poorer psychosocial functioning [14] as well as an increased relapse rates [15], higher suicidal ideation and attempts, higher number of li…”
BackgroundBerlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412 · cited 2×
“It is important to evaluate patients with TRD specifically for a history of manic or hypomanic episodes to rule out bipolar spectrum disorders since depressive episodes may be the (only) clinical presentation of Bipolar Disorders (BDs) for many years [28].”
BackgroundIs bipolar disorder still underdiagnosed? Are antidepressants overutilized?
Ghaemi, S. N., Sachs, G. S., M. Chiou, A., Pandurangi, A. K., & Goodwin, F. K. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00076-7 · Cited by 376
Crossley, N. A., & Bauer, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0617 · Cited by 246
Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1113 · Cited by 229
Chandler, G. M., Iosifescu, D. V., Pollack, M. H., Targum, S. D., & Fava, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00102.x · Cited by 158 · cited 1×
“First step should be an appropriate anamnesis, eventually integrating validated instruments as the Antidepressant Treatment History Questionnaire (ATRQ) [25, 26].”
MethodSequenced Treatment Alternatives to Relieve Depression (STAR*D): Part 2: Study Outcomes
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20081001-05 · Cited by 115 · cited 1×
“7%); authors concluded that no specific antidepressant treatment was superior to any other one, with CBT role remaining a debated issue [40].”
Background
Research works printed but not linked: 43
- Mathew SJ. Treatment-resistant depression: recent developments and future directions Depress Anxiety 2008; 25 (12) : 989-2. · DOI · Paper page
- Little A. Treatment-resistant depression Am Fam Physician 2009; 80 (2) : 167-72.
- Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches Biol Psychiatry 2008; 63 (7) : 699-704. · DOI · Paper page
- Petersen T, Papakostas GI, Posternak MA, et al. Empirical testing of two models for staging antidepressant treatment resistance J Clin Psychopharmacol 2005; 25 (4) : 336-41. · DOI · Paper page
- Corey-Lisle PK, Nash R, Stang P, Swindle R. Response, partial response, and nonresponse in primary care treatment of depression Arch Intern Med 2004; 164 (11) : 1197-204. · DOI · Paper page
- Rush AJ, Trivedi M, Carmody TJ, et al. One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies Biol Psychiatry 2004; 56 (1) : 46-53. · DOI
- Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry 2006; 163 (1) : 28-40. · DOI · Paper page
- Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD Eur Neuropsychopharmacol 2009; 19 (1) : 34-40. · DOI · Paper page
- Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial Biol Psychiatry 2005; 58 (5) : 347-54. · DOI · Paper page
- Papakostas GI, Petersen T, Denninger JW, et al. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine J Clin Psychopharmacol 2004; 24 (5) : 507-11. · DOI · Paper page
- Papakostas GI, Petersen T, Pava J, et al. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome J Nerv Ment Dis 2003; 191 (7) : 444-9. · DOI · Paper page
- Snaith RP. Hamilton rating scale for depression Br J Psychiatry 1977; 131 : 431-2. · DOI
- Malhi GS, Parker GB, Crawford J, Wilhelm K, Mitchell PB. Treatment-resistant depression: resistant to definition? Acta Psychiatr Scand 2005; 112 (4) : 302-9. · DOI · Paper page
- Thase ME. The need for clinically relevant research on treatment-resistant depression J Clin Psychiatry 2001; 62 (4) : 221-4. · DOI · Paper page
- Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression J Clin Psychiatry 2006; 67 (Suppl 6) : 16-22. · DOI · Paper page
- Nierenberg AA, White K. What next? A review of pharmacologic strategies for treatment resistant depression Psychopharmacol Bull 1990; 26 (4) : 429-60.
- Thase ME, Friedman ES, Howland RH. Management of treatment-resistant depression: psychotherapeutic perspectives J Clin Psychiatry 2001; 62 (Suppl 18) : 18-24.
- Thase ME. Management of patients with treatment-resistant depression J Clin Psychiatry 2008; 69 (3) : e8. · DOI · Paper page
- Schmauss M, Messer T. Treatment-Resistant Depression Fortschr Neurol Psychiatr 2010 ; 78 (3) : 169-83. · doi:10.1055/s-0028-1109692
- Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history? J Affect Disord 2003; 75 (2) : 115-24. · DOI
- APA. Ed Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition-Text Revision (DSM-IV-TR). Washington, D.C. 2000.
- Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders J Clin Psychiatry 1997; 58 (Suppl 13) : 23-9.
- Souery D, Amsterdam J, de Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria Eur Neuropsychopharmacol 1999; 9 (1-2) : 83-91. · DOI · Paper page
- Bannan N. Multimodal therapy of treatment resistant depression: a study and analysis Int J Psychiatry Med 2005; 35 (1) : 27-39. · DOI
- Hamann S. Blue genes: wiring the brain for depression Nat Neurosci 2005; 8 (6) : 701-3. · DOI
- Giacobbe P, Mayberg HS, Lozano AM. Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation Exp Neurol 2009; 219 (1) : 44-52. · DOI · Paper page
- Fountoulakis KN, Gonda X, Rihmer Z, Fokas C, Iacovides A. Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study Ann Gen Psychiatry 2008; 7 : 22. · DOI · Paper page
- Elliott RL. Depression in primary care Ethn Dis 2007; 17 (Suppl 2) : S2-28-33.
- Fraguas R Jr, Henriques SG Jr, De Lucia MS, et al. The detection of depression in medical setting: a study with PRIME-MD J Affect Disord 2006; 91 (1) : 11-7. · DOI
- Preskorn SH. Results of the STAR*D study: implications for clinicians and drug developers J Psychiatr Pract 2009; 15 (1) : 45-9. · DOI
- Kennedy SH, Lam RW. Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics Bipolar Disord 2003; 5 (Suppl 2) : 36-47. · DOI · Paper page
- Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials Am J Psychiatry 2009; 166 (9) : 980-1. · DOI · Paper page
- Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res 1997; 73 (3) : 159-71. · DOI · Paper page
- Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J Affect Disord 2005; 84 (2-3) : 251-7. · DOI · Paper page
- Faravelli C, Gorini Amedei S, Scarpato MA, Faravelli L. Bipolar Disorder: an impossible diagnosis Clin Pract Epidemol Ment Health 2009; 5 : 13. · DOI
- Sharma V. Treatment resistance in unipolar depression: Is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis? Med Hypotheses 2006; 67 (5) : 1142-5. · DOI
- Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire J Affect Disord 2005; 85 (1-2) : 3-16. · DOI · Paper page
- Hantouche EG, Akiskal HS, Lancrenon S, Chatenet-Duchene L. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study J Affect Disord 2005; 84 (2-3) : 243-9. · DOI
- Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients J Affect Disord 2005; 88 (2) : 217-33. · DOI · Paper page
- Benazzi F. Depressive mixed states: unipolar and bipolar II Eur Arch Psychiatry Clin Neurosci 2000; 250 (5) : 249-53. · DOI
- Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone Am J Psychiatry 2006; 163 (2) : 210-6. · DOI · Paper page
- Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression Bipolar Disord 2008; 10 (8) : 957-68. · DOI · Paper page
- Pacchiarotti I, Mazzarini L, Colom F, et al. Treatment-resistant bipolar depression: towards a new definition Acta Psychiatr Scand 2009; 120 (6) : 429-0. · DOI · Paper page
Cited by
Mota-Pereira, J., Silverio, J., Carvalho, S., Ribeiro, J. C., Fonte, D., & Ramos, J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.02.005 · Cited by 257
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Solmi, M., Monaco, F., Veronese, N., De Berardis, D., & de Bartolomeis, A. (2018) · Bipolar Disorders · doi:10.1111/bdi.12612 · Cited by 93
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Self-citationFornaro, M., Stubbs, B., De Berardis, D., Perna, G., Valchera, A., Veronese, N., Solmi, M., & Ganança, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020241 · Cited by 53
Self-citation
Metadata
- Authors
- Fornaro, M., & Giosuè, P.
- Venue
- Clinical Practice & Epidemiology in Mental Health
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-05-04
- Volume
- 06
- Issue
- 1
- Pages
- 20-24
- ISSN
- 1745-0179 (ISSN-L)
- OpenAlex
- W1990545513
- Cited by
- 42
- References
- 11
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Nosology of Treatment Resistant Depression: A Controversy Resistant to Revision. https://app.cochat.ai/papers/10.2174/1745017901006010020
- The paper
- Fornaro, M., & Giosuè, P. (2010). Current Nosology of Treatment Resistant Depression: A Controversy Resistant to Revision. Clinical Practice & Epidemiology in Mental Health. https://doi.org/10.2174/1745017901006010020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.